Western Companies Moderna announced topline results from a Phase 3 pivotal trial evaluating mRNA-1647, an investigational cytomegalovirus (CMV) vaccine. The study did not meet its primary efficacy endpoint of preventing...
South Africa — Biovac (WHO mRNA hub) Sept 2025 — The Biovac Institute (South Africa) is scaling mRNA manufacturing capacity as a core partner of WHO’s mRNA Technology Transfer Programme, with roles spanning technology...
A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed. The study involved 499...